Potential application of induced pluripotent stem cells in cell replacement therapy for parkinson's disease

CNS and Neurological Disorders - Drug Targets

Volumn 10, Issue 4, 2011, Pages 449-458

  Chen, L W ^a   Kuang, F ^a   Wei, L C ^a   Ding, Y X ^a   Yung, K K L ^b   Chan, Y S ^c  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Disease pathology; Disease therapy; Ips cells; Parkinson's disease; Personalized medicine

Indexed keywords

KRUPPEL LIKE FACTOR 4; LIN28 PROTEIN; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL NUCLEUS TRANSPLANTATION; CELL THERAPY; CELL TRANSFORMATION; CLINICAL TRIAL (TOPIC); DNA METHYLATION; EMBRYONIC STEM CELL; EXPERIMENTAL THERAPY; GENE EXPRESSION; HUMAN; MICROARRAY ANALYSIS; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PLURIPOTENT STEM CELL; PROBLEM SOLVING; PROTEIN PROCESSING; SAFETY; SOMATIC CELL; TREATMENT INDICATION;

EID: 79956257596     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/187152711795563994     Document Type: Article

References (96)

1. Olanow, C.W.; Tatton, W.G. Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci., 1999, 22, 123-144.
2. Fernandez-Espejo, E. Pathogenesis of Parkinson's disease:prospects of neuroprotective and restorative therapies. Mol.Neurobiol., 2004, 29, 15-30.
3. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cellsfrom mouse embryonic and adult fibroblast cultures by definedfactors. Cell, 2006, 126, 663-676.
4. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of pluripotent stem cells fromadult human fibroblasts by defined factors. Cell, 2007, 131, 861-872.
5. Yamanaka, S. Strategies and new developments in the generationof patient-specific pluripotent stem cells. Cell Stem Cell, 2007, 1,39-49.
6. Wernig, M.; Zhao, J.P.; Pruszak, J.; Hedlund, E.; Fu, D.; Soldner, F.; Broccoli, V.; Constantine-Paton, M.; Isacson, O.; Jaenisch, R. Neurons derived from reprogrammed fibroblasts functionallyintegrate into the fetal brain and improve symptoms of rats withParkinson's disease. Proc. Natl. Acad. Sci. USA, 2008, 105, 5856-5861.
7. Park, I.H.; Arora, N.; Huo, H.; Maherali, N.; Ahfeldt, T.; Shimamura, A.; Lensch, M.W.; Cowan, C.; Hochedlinger, K.; Daley, G.Q. Disease-specific induced pluripotent stem cells. Cell,2008, 134, 877-886.
8. Soldner, F.; Hockemeyer, D.; Beard, C.; Gao, Q.; Bell, G.W.; Cook, E.G.; Hargus, G.; Blak, A.; Cooper, O.; Mitalipova, M.; Isacson, O.; Jaenisch, R. Parkinson's disease patient-derivedinduced pluripotent stem cells free of viral reprogramming factors. Cell, 2009, 136, 964-977.
9. Yamanaka, S. A fresh look at iPS cells. Cell, 2009, 137, 13-17.
10. Abeliovich, A.; Doege, C.A. Reprogramming therapeutics: iPS cellprospects for neurodegenerative disease. Neuron, 2009, 6, 337-339.
11. Amabile, G.; Meissner, A. Induced pluripotent stem cells: currentprogress and potential for regenerative medicine. Trends Mol.Med., 2009, 15, 59-68.
12. Webb, S. iPS cell technology gains momentum in drug discovery. Nat. Rev. Drug Discov., 2009, 8, 263-264.
13. Huangfu, D.; Osafune, K.; Maehr, R.; Guo, W.; Eijkelenboom, A.; Chen, S.; Muhlestein, W.; Melton, D.A. Induction of pluripotentstem cells from primary human fibroblasts with only Oct4 andSox2. Nat. Biotechnol., 2008, 26, 1269-1275.
14. Yu, J.; Vodyanik, M.A.; Smuga-Otto, K.; Antosiewicz-Bourget, J.; Frane, J.L.; Tian, S.; Nie, J.; Jonsdottir, G.A.; Ruotti, V.; Stewart, R.; Slukvin, I.I.; Thomson, J.A. Induced pluripotent stem cell linesderived from human somatic cells. Science, 2007, 318, 1917-1920.
15. Aasen, T.; Raya, A.; Barrero, M.J.; Garreta, E.; Consiglio, A.; Gonzalez, F.; Vassena, R.; Bilić, J.; Pekarik, V.; Tiscornia, G.; Edel, M.; Boué, S.; Belmonte, J.C. Efficient and rapid generationof induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol., 2008, 26, 1276-1284.
16. Aoi, T.; Yae, K.; Nakagawa, M.; Ichisaka, T.; Okita, K.; Takahashi, K.; Chiba, T.; Yamanaka, S. Generation of pluripotentstem cells from adult mouse liver and stomach cells. Science, 2008,321, 699-702.
17. Ebert, A.D.; Yu, J.; Rose, F.F. Jr; Mattis, V.B.; Lorson, C.L.; Thomson, J.A.; Svendsen, C.N. Induced pluripotent stem cells froma spinal muscular atrophy patient. Nature, 2009, 457, 277-80.
18. Eminli, S.; Utikal, J.; Arnold, K.; Jaenisch, R.; Hochedlinger, K. Reprogramming of neural progenitor cells into induced pluripotentstem cells in the absence of exogenous Sox2 expression. StemCells, 2008, 26, 2467-2474.
19. Ezashi, T.; Telugu, B.P.; Alexenko, A.P.; Sachdev, S.; Sinha, S.; Roberts, R.M. Derivation of induced pluripotent stem cells frompig somatic cells. Proc. Natl. Acad. Sci. USA, 2009, 106, 10993-10998.
20. Gallicano, G.I.; Golestaneh, N.; Kokkinaki, M.; Pant, D.; Jiang, J.; Destefano, D.; Fernandez-Bueno, C.; Rome, J.D.; Haddad, B.R.; Dym, M. Pluripotent stem cells derived from adult human testes. Stem Cells Dev., 2009, 18(8), 1115-11126.
21. Hanna, J.; Markoulaki, S.; Schorderet, P.; Carey, B.W.; Beard, C.; Wernig, M.; Creyghton, M.P.; Steine, E.J.; Cassady, J.P.; Foreman, R.; Lengner, C.J.; Dausman, J.A.; Jaenisch, R. Directreprogramming of terminally differentiated mature B lymphocytesto pluripotency. Cell, 2008, 133, 2502-2564.
22. Kunisato, A.; Wakatsuki, M.; Kodama, Y.; Shinba, H.; Ishida, I.; Nagao, K. Generation of induced pluripotent stem cells by efficientreprogramming of adult bone marrow cells. Stem Cells Dev., 2010,19(2), 229-238.
23. Liu, H.; Zhu, F.; Yong, J.; Zhang, P.; Hou, P.; Li, H.; Jiang, W.; Cai, J.; Liu, M.; Cui, K.; Qu, X.; Xiang, T.; Lu, D.; Chi, X.; Gao, G.; Ji, W.; Ding, M.; Deng, H. Generation of induced pluripotentstem cells from adult rhesus monkey fibroblasts. Cell Stem Cell,2008, 3, 587-590.
24. Loh, Y.H.; Agarwal, S.; Park, I.H.; Urbach, A.; Huo, H.; Heffner, G.C.; Kim, K.; Miller, J.D.; Ng, K.; Daley, G.Q. Generation ofinduced pluripotent stem cells from human blood. Blood, 2009,113, 5476-5479.
25. Lowry, W.E.; Richter, L.; Yachechko, R.; Pyle, A.D.; Tchieu, J.; Sridharan, R.; Clark, A.T.; Plath, K. Generation of human inducedpluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad.Sci. USA, 2008, 105, 2883-2888.
26. Maherali, N.; Sridharan, R.; Xie, W.; Utikal, J.; Eminli, S.; Arnold, K.; Stadtfeld, M.; Yachechko, R.; Tchieu, J.; Jaenisch, R.; Plath, K.; Hochedlinger, K. Directly reprogrammed fibroblasts showglobal epigenetic remodeling and widespread tissue contribution. Cell Stem Cell, 2007, 1, 55-70.
27. Mali, P.; Ye, Z.; Hommond, H.H.; Yu, X.; Lin, J.; Chen, G.; Zou, J.; Cheng, L. Improved efficiency and pace of generating inducedpluripotent stem cells from human adult and fetal fibroblasts. StemCells, 2008, 26, 1998-2005.
28. Meissner, A.; Wernig, M.; Jaenisch, R. Direct reprogramming ofgenetically unmodified fibroblasts into pluripotent stem cells. Nat.Biotechnol., 2007, 5, 1177-1181.
29. Okabe, M.; Otsu, M.; Ahn, D.H.; Kobayashi, T.; Morita, Y.; Wakiyama, Y.; Onodera, M.; Eto, K.; Ema, H.; Nakauchi, H. Definitive proof for direct reprogramming of hematopoietic cells topluripotency. Blood, 2009, 114(9), 1764-1767.
30. Okita, K.; Ichisaka, T.; Yamanaka, S. Generation of germlinecompetentinduced pluripotent stem cells. Nature, 2007, 448, 313-317.
31. Pereira, C.F.; Terranova, R.; Ryan, N.K.; Santos, J.; Morris, K.J.; Cui, W.; Merkenschlager, M.; Fisher, A.G. Heterokaryon-basedreprogramming of human B lymphocytes for pluripotency requiresOct4 but not Sox2. PLoS Genet., 2008, 4, e1000170.
32. Qin, D.; Gan, Y.; Shao, K.; Wang, H.; Li, W.; Wang, T.; He, W.; Xu, J.; Zhang, Y.; Kou, Z.; Zeng, L.; Sheng, G.; Esteban, M.A.; Gao, S.; Pei, D. Mouse meningiocytes express Sox2 and yield highefficiency of chimeras after nuclear reprogramming withexogenous factors. J. Biol. Chem., 2008, 283, 33730-33735.
33. Qin, Y.; Ji, H.; Wu, Y.; Liu, H. Chromosomal instability of murineadipose tissue-derived mesenchymal stem cells in long-term cultureand development of cloned embryos. Cloning Stem Cells, 2009,11(3), 445-452.
34. Stadtfeld, M.; Brennand, K.; Hochedlinger, K. Reprogramming ofpancreatic beta cells into induced pluripotent stem cells. Curr.Biol., 2008, 18, 890-894.
35. Tateishi, K.; He, J.; Taranova, O.; Liang, G.; D'Alessio, A.C.; Zhang, Y. Generation of insulin-secreting islet-like clusters fromhuman skin fibroblasts. J. Biol. Chem., 2008, 283, 31601-31607.
36. Rody, A.; Karn, T.; Ruckhaeberle, E.; Hanker, L.; Gaetje, R.; Holtrich, U.; Kaufmann, M. Differentially expressed genes ofreprogrammed human pluripotent stem cells in breast cancer. Eur.J. Cancer, 2008, 44, 1789-1792.
37. Brambrink, T.; Foreman, R.; Welstead, G.G.; Lengner, C.J.; Wernig, M.; Suh, H.; Jaenisch, R. Sequential expression ofpluripotency markers during direct reprogramming of mousesomatic cells. Cell Stem Cell, 2008, 2, 151-159.
38. Loh, Y.H.; Ng, J.H.; Ng, H.H. Molecular framework underlyingpluripotency. Cell Cycle, 2008, 7, 885-891.
39. Hochedlinger, K.; Plath, K. Epigenetic reprogramming and inducedpluripotency. Development, 2009, 136, 509-523.
40. Deng, J.; Shoemaker, R.; Xie, B.; Gore, A.; LeProust, E.M.; Antosiewicz-Bourget, J.; Egli, D.; Maherali, N.; Park, I.H.; Yu, J.; Daley, G.Q.; Eggan, K.; Hochedlinger, K.; Thomson, J.; Wang, W.; Gao, Y.; Zhang, K. Targeted bisulfite sequencing reveals changesin DNA methylation associated with nuclear reprogramming. Nat. Biotechnol., 2009, 27, 353-360.
41. Chambers, S.M.; Fasano, C.A.; Papapetrou, E.P.; Tomishima, M.; Sadelain, M.; Studer, L. Highly efficient neural conversion ofhuman ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol., 2009, 27, 275-280.
42. Marion, R.M.; Strati, K.; Li, H.; Tejera, A.; Schoeftner, S.; Ortega, S.; Serrano, M.; Blasco, M.A. Telomeres acquire embryonic stemcell characteristics in induced pluripotent stem cells. Cell StemCell, 2009, 4, 141-154.
43. Nishikawa, S.; Goldstein, R.A.; Nierras, C.R. The promise ofhuman induced pluripotent stem cells for research and therapy. Nat.Rev. Mol. Cell Biol., 2008, 9, 725-729.
44. Donohoe, M.E.; Silva, S.S.; Pinter, S.F.; Xu, N.; Lee, J.T. Thepluripotency factor Oct4 interacts with Ctcf and also controls Xchromosomepairing and counting. Nature, 2009, 460(7251), 128-132.
45. Kim, J.B.; Sebastiano, V.; Wu, G.; Araúzo-Bravo, M.J.; Sasse, P.; Gentile, L.; Ko, K.; Ruau, D.; Ehrich, M.; van den Boom, D.; Meyer, J.; Hübner, K.; Bernemann, C.; Ortmeier, C.; Zenke, M.; Fleischmann, B.K.; Zaehres, H.; Schöler, H.R. Oct4-inducedpluripotency in adult neural stem cells. Cell, 2009, 136, 411-419.
46. Kim, J.B.; Zaehres, H.; Wu, G.; Gentile, L.; Ko, K.; Sebastiano, V.; Araúzo-Bravo, M.J.; Ruau, D.; Han, D.W.; Zenke, M.; Schöler, H.R. Pluripotent stem cells induced from adult neural stem cells byreprogramming with two factors. Nature, 2008, 454, 646-650.
47. Guo, G.; Yang, J.; Nichols, J.; Hall, J.S.; Eyres, I.; Mansfield, W.; Smith, A. Klf4 reverts developmentally programmed restriction ofground state pluripotency. Development, 2009, 136, 1063-1069.
48. Nakagawa, M.; Koyanagi, M.; Tanabe, K.; Takahashi, K.; Ichisaka, T.; Aoi, T.; Okita, K.; Mochiduki, Y.; Takizawa, N.; Yamanaka, S. Generation of induced pluripotent stem cells without Myc frommouse and human fibroblasts. Nat. Biotechnol., 2008, 26, 101-106.
49. Darr, H.; Benvenisty, N. Genetic analysis of the role of thereprogramming gene LIN-28 in human embryonic stem cells. StemCells, 2009, 27, 352-362.
50. Scheper, W.; Copray, S. The Molecular Mechanism of InducedPluripotency: A Two-Stage Switch. Stem Cell Rev. Rep., 2009,5(3), 204-223.
51. Sridharan, R.; Tchieu, J.; Mason, M.J.; Yachechko, R.; Kuoy, E.; Horvath, S.; Zhou, Q.; Plath, K. Role of the murine reprogrammingfactors in the induction of pluripotency. Cell, 2009, 136, 364-377.
52. Stadtfeld, M.; Maherali, N.; Breault, D.T.; Hochedlinger, K. Defining molecular cornerstones during fibroblast to iPS cellreprogramming in mouse. Cell Stem Cell, 2008, 2, 230-240.
53. Suzuki, K.; Mitsui, K.; Aizawa, E.; Hasegawa, K.; Kawase, E.; Yamagishi, T.; Shimizu, Y.; Suemori, H.; Nakatsuji, N.; Mitani, K. Highly efficient transient gene expression and gene targeting inprimate embryonic stem cells with helper-dependent adenoviralvectors. Proc. Natl. Acad. Sci. USA, 2008, 105, 13781-13786.
54. Lowry, W.E.; Plath, K. The many ways to make an iPS cell. Nat.Biotechnol., 2008, 26, 1246-1248.
55. Tweedell, K.S. New paths to pluripotent stem cells. Curr. StemCell Res. Ther., 2008, 3, 151-162.
56. Judson, R.L.; Babiarz, J.E.; Venere, M.; Blelloch, R. Embryonicstem cell-specific microRNAs promote induced pluripotency. Nat.Biotechnol., 2009, 27(5), 459-461.
57. Liao, J.; Wu, Z.; Wang, Y.; Cheng, L.; Cui, C.; Gao, Y.; Chen, T.; Rao, L.; Chen, S.; Jia, N.; Dai, H.; Xin, S.; Kang, J.; Pei, G.; Xiao, L. Enhanced efficiency of generating induced pluripotent stem[iPS] cells from human somatic cells by a combination of sixtranscription factors. Cell Res., 2008, 18, 600-603.
58. Park, I.H.; Lerou, P.H.; Zhao, R.; Huo, H.; Daley, G.Q. Generation of human-induced pluripotent stem cells. Nat. Protoc., 2008, 3,1180-1186.
59. Park, I.H.; Zhao, R.; West, J.A.; Yabuuchi, A.; Huo, H.; Ince, T.A.; Lerou, P.H.; Lensch, M.W.; Daley, G.Q. Reprogramming of humansomatic cells to pluripotency with defined factors. Nature, 2008,451, 141-146.
60. Hanna, J.; Wernig, M.; Markoulaki, S.; Sun, C.W.; Meissner, A.; Cassady, J.P.; Beard, C.; Brambrink, T.; Wu, L.C.; Townes, T.M.; Jaenisch, R. Treatment of sickle cell anemia mouse model with iPScells generated from autologous skin. Science, 2007, 318, 1920-1923.
61. Dimos, J.T.; Rodolfa, K.T.; Niakan, K.K.; Weisenthal, L.M.; Mitsumoto, H.; Chung, W.; Croft, G.F.; Saphier, G.; Leibel, R.; Goland, R.; Wichterle, H.; Henderson, C.E.; Eggan, K. Inducedpluripotent stem cells generated from patients with ALS can bedifferentiated into motor neurons. Science, 2008, 321, 1218-1221.
62. Karumbayaram, S.; Novitch, B.G.; Patterson, M.; Umbach, J.A.; Richter, L.; Lindgren, A.; Conway, A.E.; Clark, A.T.; Goldman, S.A.; Plath, K.; Wiedau-Pazos, M.; Kornblum, H.I.; Lowry, W.E.Directed differentiation of human-induced pluripotent stem cellsgenerates active motor neurons. Stem Cells, 2009, 27, 806-811.
63. Tateishi, K.; Takehara, N.; Matsubara, H.; Oh, H. Stemming heartfailure with cardiac- or reprogrammed-stem cells. J. Cell Mol.Med., 2008, 12, 2217-2232.
64. Schenke-Layland, K.; Rhodes, K.E.; Angelis, E.; Butylkova, Y.; Heydarkhan-Hagvall, S.; Gekas, C.; Zhang, R.; Goldhaber, J.I.; Mikkola, H.K.; Plath, K.; MacLellan, W.R. Reprogrammed mousefibroblasts differentiate into cells of the cardiovascular andhematopoietic lineages. Stem Cells, 2008, 26, 1537-1546.
65. Mauritz, C.; Schwanke, K.; Reppel, M.; Neef, S.; Katsirntaki, K.; Maier, L.S.; Nguemo, F.; Menke, S.; Haustein, M.; Hescheler, J.; Hasenfuss, G.; Martin, U. Generation of functional murine cardiacmyocytes from induced pluripotent stem cells. Circulation, 2008,118, 507-517.
66. Narazaki, G.; Uosaki, H.; Teranishi, M.; Okita, K.; Kim, B.; Matsuoka, S.; Yamanaka, S.; Yamashita, J.K. Directed andsystematic differentiation of cardiovascular cells from mouseinduced pluripotent stem cells. Circulation, 2008, 118, 498-506.
67. Zhang, J.; Wilson, G.F.; Soerens, A.G.; Koonce, C.H.; Yu, J.; Palecek, S.P.; Thomson, J.A.; Kamp, T,J. Functionalcardiomyocytes derived from human induced pluripotent stemcells. Circ. Res., 2009, 104, e30-e41.
68. Xie, C.Q.; Huang, H.; Wei, S.; Song, L.S.; Zhang, J.; Ritchie, R.P.; Chen, L.; Zhang, M.; Chen, Y.E. A Comparison of Murine SmoothMuscle Cells Generated from Embryonic versus InducedPluripotent Stem Cells. Stem Cells Dev., 2009, 18, 741-748.
69. Senju, S.; Haruta, M.; Matsunaga, Y.; Fukushima, S.; Ikeda, T.; Takahashi, K.; Okita, K.; Yamanaka, S.; Nishimura, Y. Characterization of dendritic cells and macrophages generated bydirected differentiation from mouse induced pluripotent stem cells. Stem Cells, 2009, 27, 1021-1031.
70. Xu, D.; Alipio, Z.; Fink, L.M.; Adcock, D.M.; Yang, J.; Ward, D.C.; Ma, Y. Phenotypic correction of murine hemophilia A usingan iPS cell-based therapy. Proc. Natl. Acad. Sci. USA, 2009, 106,808-813.
71. Darabi, R.; Perlingeiro, R.C. Lineage-specific reprogramming as astrategy for cell therapy. Cell Cycle, 2008, 7, 1732-1737.
72. Gottweis, H.; Minger, S. iPS cells and the politics of promise. Nat.Biotechnol., 2008, 26, 271-272.
73. Carey, B.W.; Markoulaki, S.; Hanna, J.; Saha, K.; Gao, Q.; Mitalipova, M.; Jaenisch, R. Reprogramming of murine and humansomatic cells using a single polycistronic vector. Proc. Natl. Acad.Sci. USA, 2009, 106, 157-162.
74. Chang, C.W.; Lai, Y.S.; Pawlik, K.M.; Liu, K.; Sun, C.W.; Li, C.; Schoeb, T.R.; Townes, T.M. Polycistronic lentiviral vector for "Hitand Run" reprogramming of adult skin fibroblasts to inducedpluripotent stem cells. Stem Cells, 2009, 27, 1042-1049.
75. Hotta, A.; Cheung, A.Y.; Farra, N.; Vijayaragavan, K.; Séguin, C.A.; Draper, J.S.; Pasceri, P.; Maksakova, I.A.; Mager, D.L.; Rossant, J.; Bhatia, M.; Ellis, J. Isolation of human iPS cells usingEOS lentiviral vectors to select for pluripotency. Nat. Methods,2009, 6, 370-376.
76. Sommer, C.A.; Stadtfeld, M.; Murphy, G.J.; Hochedlinger, K.; Kotton, D.N.; Mostoslavsky, G. iPS cell generation using a singlelentiviral stem cell cassette. Stem Cells, 2009, 27, 543-549.
77. Hotta, A.; Ellis, J. Retroviral vector silencing during iPS cellinduction: an epigenetic beacon that signals distinct pluripotentstates. J. Cell Biochem., 2008, 105, 940-948.
78. Kaji, K.; Norrby, K.; Paca, A.; Mileikovsky, M.; Mohseni, P.; Woltjen, K. Virus-free induction of pluripotency and subsequentexcision of reprogramming factors. Nature, 2009, 458, 771-775.
79. Varas, F.; Stadtfeld, M.; De Andres-Aguayo, L.; Maherali, N.; di Tullio, A.; Pantano, L.; Notredame, C.; Hochedlinger, K.; Graf, T. Fibroblast derived induced pluripotent stem cells show no commonretroviral vector insertions. Stem Cells, 2009, 27, 300-306.
80. Okita, K.; Nakagawa, M.; Hyenjong, H.; Ichisaka, T.; Yamanaka,S. Generation of mouse induced pluripotent stem cells without viralvectors. Science, 2008, 322, 949-953.
81. Stadtfeld, M.; Nagaya, M.; Utikal, J.; Weir, G.; Hochedlinger, K. Induced pluripotent stem cells generated without viral integration. Science, 2008, 322, 945-949.
82. Yu, J.; Hu, K.; Smuga-Otto, K.; Tian, S.; Stewart, R.; Slukvin, I.I.; Thomson, J.A. Human induced pluripotent stem cells free of vectorand transgene sequences. Science, 2009, 324(5928), 797-801.
83. Markoulaki, S.; Hanna, J.; Beard, C.; Carey, B.W.; Cheng, A.W.; Lengner, C.J.; Dausman, J.A.; Fu, D.; Gao, Q.; Wu, S.; Cassady, J.P.; Jaenisch, R. Transgenic mice with defined combinations ofdrug-inducible reprogramming factors. Nat. Biotechnol., 2009, 27,169-171.
84. Patel, M,; Yang, S. Advances in Reprogramming Somatic Cells toInduced Pluripotent Stem Cells. Stem Cell Rev., 2010, 6(3), 367-380.
85. Kiskinis, E.; Eggan, K. Progress toward the clinical application ofpatient-specific pluripotent stem cells. J. Clin. Invest., 2010,120(1), 51-59.
86. Gunaseeli, I.; Doss, M.X.; Antzelevitch, C.; Hescheler, J.; Sachinidis, A. Induced Pluripotent Stem Cells as a Model forAccelerated Patient- and Disease-specific Drug Discovery. Curr. Med. Chem., 2010, 17, 759-766.
87. Hyun, I.; Hochedlinger, K.; Jaenisch, R.; Yamanaka, S. Newadvances in iPS cell research do not obviate the need for humanembryonic stem cells. Cell Stem Cell, 2007, 1, 367-368.
88. Cyranoski, D. Stem cells: 5 things to know before jumping on theiPS bandwagon. Nature, 2008, 452, 406-408.
89. Ellis, J.; Bruneau, B.G.; Keller, G.; Lemischka, I.R.; Nagy, A.; Rossant, J.; Srivastava, D.; Zandstra, P.W.; Stanford, W.L. Alternative induced pluripotent stem cell characterization criteriafor in vitro applications. Cell Stem Cell, 2009, 4, 198-199.
90. Olanow, C.W.; Kordower, J.H.; Lang, A.E.; Obeso, J. A. Dopaminergic transplantation for Parkinson's disease: current statusand future prospects. Ann. Neurol., 2009, 66, 591-596.
91. Martinez-Fernandez, A.; Nelson, T.J.; Ikeda, Y.; Terzic, A. c-MYCindependent nuclear reprogramming favors cardiogenic potential ofinduced pluripotent stem cells. J. Cardiovasc. Transl. Res., 2010, 3,13-23.
92. Balasubramanian, S.; Babai, N.; Chaudhuri, A.; Qiu, F.; Bhattacharya, S.; Dave, B.J.; Parameswaran, S.; Carson, S.D.; Thoreson, W.B.; Sharp, J.G.; Rao, M.; Ahmad, I. Non cellautonomousreprogramming of adult ocular progenitors: generationof pluripotent stem cells without exogenous transcription factors. Stem Cells, 2009, 27, 3053-3062.
93. Okita, K.; Yamanaka, S. Induction of pluripotency by definedfactors. Exp. Cell Res., 2010, 316(16), 2565-2570.
94. Zhao, H.X.; Li, Y.; Jin, H.F.; Xie, L.; Liu, C.; Jiang, F.; Luo, Y.N.; Yin, G.W.; Li, Y.; Wang, J.; Li, L.S.; Yao, Y.Q.; Wang, X.H. Rapid and efficient reprogramming of human amnion-derived cellsinto pluripotency by three factors OCT4/SOX2/NANOG. Differentiation, 2010, 80(2-3), 123-129.
95. Mallanna, S.K.; Rizzino, A. Emerging roles of microRNAs in thecontrol of embryonic stem cells and the generation of inducedpluripotent stem cells. Dev. Biol., 2010, 344(1), 16-25.
96. Cho, H.J.; Lee, C.S.; Kwon, Y.W.; Paek, J.S.; Lee, S.H.; Hur, J.; Lee, E.J.; Roh, T.Y.; Chu, I.S.; Leem, S.H.; Kim, Y.; Kang, H.J.; Park, Y.B.; Kim, H.S. Induction of pluripotent stem cells fromadult somatic cells by protein-based reprogramming without genetic manipulation. Blood, 2010, 116(3), 386-395.